| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/10/2013 | EP2575821A2 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 04/10/2013 | EP2575805A2 Methods of treatment |
| 04/10/2013 | EP2575792A1 Biguanide compounds and its use for treating cancer |
| 04/10/2013 | EP2575758A1 Formulation for osteoporosis |
| 04/10/2013 | EP2575502A2 Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore |
| 04/10/2013 | EP2575496A1 Collagen powder |
| 04/10/2013 | CN103038255A Novel anti-CD98 antibody and use thereof |
| 04/10/2013 | CN103038254A Antagonist anti-il-7 receptor antibodies and methods |
| 04/10/2013 | CN103038238A Crystal of thienopyrimidine derivative |
| 04/10/2013 | CN103038223A Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents |
| 04/10/2013 | CN103037939A Methods and compositions for treating diabetes with iPS derived pancreatic beta-like cells |
| 04/10/2013 | CN103037901A Cd36 inhibition to control obesity and insulin sensitivity |
| 04/10/2013 | CN103037891A Methods of treating diabetes and compositions capable of same |
| 04/10/2013 | CN103037878A Lipid metabolism-improving agent |
| 04/10/2013 | CN103037877A Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
| 04/10/2013 | CN103037715A Nutritional compositions |
| 04/10/2013 | CN103030714A Preparation method of low-molecular-weight chitosan oligosaccharide sulfamide derivate with hypoglycemic activity |
| 04/10/2013 | CN103030713A Preparation method of low-molecular-weight glucan-niacin polymer with hypolipidemic activity |
| 04/10/2013 | CN103030687A Anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus, coding gene thereof and application in pharmacy |
| 04/10/2013 | CN103030678A Method for preparing rare ginsenoside from malonyl ginsenoside |
| 04/10/2013 | CN103030654A Micromolecular c-Met protein kinase inhibitor |
| 04/10/2013 | CN103030646A Benzodioxane derivative, and preparation method thereof and application of derivative in medicines |
| 04/10/2013 | CN103030645A Method for preparing high-purity heme on large scale and application of heme |
| 04/10/2013 | CN103030620A Drug, food, or cosmetic which has anti-obesity agent and fat accumulation inhibiting action |
| 04/10/2013 | CN103030619A C-crystal-form 5-methyl-7-methoxyiso-flavone and preparation method, pharmaceutical compositions and application of C-crystal-form 5-methyl-7-methoxyiso-flavone |
| 04/10/2013 | CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/10/2013 | CN103028053A Traditional Chinese medicine for treating diabetes and preparation method thereof |
| 04/10/2013 | CN103027979A Process for extracting and purifying general flavone of discolorous clinquefoil roots |
| 04/10/2013 | CN103027971A Hypolipidemic health-care medicated bath formula |
| 04/10/2013 | CN103027953A Extractive containing total meroterpenoid of psidium guajave dialdehyde, and preparation method and application thereof |
| 04/10/2013 | CN103027951A Purification method of cortex mori total flavonoids |
| 04/10/2013 | CN103027934A Pharmaceutical composition and health food containing the extract of crepidiastrum denticulatum |
| 04/10/2013 | CN103027926A Pharmaceutical composition used for nutritional supplement and preparation method of oral liquid thereof |
| 04/10/2013 | CN103027913A New use of total alkaloids extracted from Fugu vermicularis, Rad tide and Saxidomus giganteus in treating diabetes |
| 04/10/2013 | CN103027911A Pharmaceutical composition, preparation and application thereof |
| 04/10/2013 | CN103027901A Capsaicin chitosan microsphere-carried enteric coated tablet and preparation method thereof |
| 04/10/2013 | CN103027900A Repaglinide tablet and preparation method thereof |
| 04/10/2013 | CN103027898A Sitagliptin sustained-release pellet and preparation method thereof |
| 04/10/2013 | CN103027155A Mulberry leaf lipid-reducing pressure-reducing health-care tea and preparation method thereof |
| 04/10/2013 | CN102641288B Nutrition combination for anti experiment beagle transportation stress |
| 04/10/2013 | CN102408973B Rhizoma polygonati health wine and preparation method thereof |
| 04/10/2013 | CN102399666B Ginseng wine and production technology thereof |
| 04/10/2013 | CN102397258B Insulin carrying microsphere and preparation method thereof |
| 04/10/2013 | CN102389566B Huidouba peptide polysaccharide-containing composition used for treating type II diabetes |
| 04/10/2013 | CN102366481B Medicine for treating diabetes and preparation method thereof |
| 04/10/2013 | CN102362994B Zinc gluconate oral liquid for strengthening spleen and stomach |
| 04/10/2013 | CN102343023B Medicinal composition and preparation method and application thereof |
| 04/10/2013 | CN102335362B Traditional Chinese medicine for treating insulin resistance of type 2 diabetes |
| 04/10/2013 | CN102309635B Traditional Chinese medicine preparation for treating diabetes |
| 04/10/2013 | CN102308898B Medicinal fresh Chinese herb tea containing Chimonanthus fragrans, and preparation method and usage thereof |
| 04/10/2013 | CN102283832B Medicinal composition for preventing or treating hypertensive obese patient and application thereof |
| 04/10/2013 | CN102245172B Oral formulations containing metformin and a-glycosidase inhibitor, and preparation method thereof |
| 04/10/2013 | CN102224924B Sea cucumber saponin-containing composition and its application in foods and drugs |
| 04/10/2013 | CN102170894B A pharmaceutical composition with the effect of treating diabetes |
| 04/10/2013 | CN102159578B Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof |
| 04/10/2013 | CN102146143B Method for preparing pectin and cellulose from extracting residues of ginseng and American ginseng and application thereof |
| 04/10/2013 | CN102125544B Inducer for activating expression of fish lipid metabolism control gene and application thereof |
| 04/10/2013 | CN102114076B Preparation method of cassia bark extract, cassia bark extract and composition and application thereof |
| 04/10/2013 | CN102070717B Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN101897964B Medicament for preventing autoimmune disease |
| 04/10/2013 | CN101664552B Stabilization of hypoxia inducible factor (HIF) alpha |
| 04/10/2013 | CN101628855B Laurane type sesquiterpene compound or derivative thereof and preparation method and application thereof |
| 04/10/2013 | CN101605784B Aza-bridged-ring compound |
| 04/10/2013 | CN101544575B Method for preparing natural 4-hydroxy-isoleucine |
| 04/10/2013 | CN101390966B Traditional Chinese medicine effective part compound recipe composition, preparation technique and anti-diabetes use thereof |
| 04/10/2013 | CN101343296B Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 04/10/2013 | CN101342207B Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia, hyperlipemia and preparation method thereof |
| 04/10/2013 | CN101301298B Hyperlipemia prophylactic and therapeutic agent |
| 04/10/2013 | CN101238222B Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus |
| 04/10/2013 | CN101058558B 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof |
| 04/09/2013 | US8415297 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/09/2013 | US8415295 Heterocyclic boronic acid compounds |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414913 Edible compositions for lowering cholesterol |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | CA2659590C Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/09/2013 | CA2619111C Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/09/2013 | CA2601501C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 04/09/2013 | CA2451116C Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 04/04/2013 | WO2013049833A1 System and method for targeted lipolysis |
| 04/04/2013 | WO2013049585A1 Arylsubstituted thiazolotriazoles and thiazoloimidazoles |
| 04/04/2013 | WO2013049293A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049289A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049287A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin- 1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | WO2013049104A1 Pyridinedione carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013049096A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048982A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
| 04/04/2013 | WO2013047889A1 Pharmaceutical composition for treating autoimmune diseases |
| 04/04/2013 | WO2013045495A1 PYRANO[3,2-c][2]BENZOPYRAN-6(2H)-ONE DERIVATIVES AND USES THEREOF |
| 04/04/2013 | WO2013044608A1 Anomeric alkyl-containing phenyl c-glucoside derivative, preparation method therefor and use thereof |
| 04/04/2013 | WO2013044511A1 Pharmaceutical composition containing riligustilide and use thereof |
| 04/04/2013 | WO2013044356A1 Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d |
| 04/04/2013 | WO2013017650A3 Formulations comprising saccharomyces boulardii and superoxide dismutase for controlling obesity |
| 04/04/2013 | WO2012174365A3 Methods for producing pancreatic precursor cells and uses thereof |
| 04/04/2013 | WO2012174035A3 A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine |
| 04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
| 04/04/2013 | WO2012154756A9 Delaying the progression of diabetes |